Caribou Biosciences (CRBU) Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Assets data on file, last reported at $149.0 million in Q1 2026.

• On a quarterly basis, Assets fell 45.55% year-over-year to $149.0 million in Q1 2026; TTM through Mar 2026 was $149.0 million, a 45.55% decrease from a year earlier, with the FY2025 full-year figure at $175.4 million, down 44.03% from the prior year.
• Assets for Q1 2026 stood at $149.0 million, down from $175.4 million in the prior quarter.
• Over the last five years, Assets for CRBU reached as high as $457.5 million in Q3 2023 and fell as low as $149.0 million in Q1 2026.
• Historically, Assets has averaged $334.0 million across 5 years, with a median of $349.6 million in 2023.
• Across the five-year window, Assets surged 166.02% in 2022 and plunged 45.55% in 2026, its largest moves.
• Year by year, Assets stood at $373.8 million in 2022, then rose by 15.64% to $432.2 million in 2023, then retreated by 27.51% to $313.3 million in 2024, then plunged by 44.03% to $175.4 million in 2025, then dropped by 15.04% to $149.0 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $149.0 million in Q1 2026, $175.4 million in Q4 2025, and $195.0 million in Q3 2025.